pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 371 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
lonvoguran
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
$NTLAIntellia Therapeutics, Inc.
0 catalysts
Marketed
mavorixafor
Xolremdi (mavorixafor)
Neutropenia
C-X-C chemokine receptor type 4
$XFORX4 Pharmaceuticals, Inc
0 catalysts
Phase 2
mavrilimumab
Rheumatoid Arthritis
Granulocyte-macrophage colony-stimulating factor receptor
← prev
page 11 of 13
next →
131
Pain89
Neurology1
MedImmune Ltd
0 catalysts
Marketed
meloxicam
Qamzova (meloxicam)
Post-Operative Pain
Nanjing Delova Biotech Co Ltd
0 catalysts
Marketed
mepolizumab
Nucala (mepolizumab)
Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)
GlaxoSmithKline LLC
0 catalysts
Marketed
methoxsalen
Methoxsalen (methoxsalen)
Vitiligo
Allergan Finance LLC
0 catalysts
Phase 3
mivocabtagene autoleucel
mivocabtagene autoleucel [INN]
Myasthenia Gravis
$KYTXKyverna Therapeutics, Inc.
0 catalysts
Marketed
mycophenolate mofetil hydrochloride
Mycophenolate Mofetil Hydrochloride (mycophenolate mofetil hydrochloride)
Heart Transplant Rejection
Meitheal Pharmaceuticals Inc
0 catalysts
Marketed
mycophenolic acid DR
Mycophenolic Acid (mycophenolic acid)
Kidney Transplant Rejection
TWi Pharmaceuticals USA Inc
0 catalysts
Phase 3
navenibart
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
$BCRXBIOCRYST PHARMACEUTICALS INC
0 catalysts
Phase 2
nemolizumab
Nemluvio (nemolizumab)
Systemic Sclerosis (Scleroderma)
Interleukin-31 receptor subunit alpha
Galderma SA
0 catalysts
pre_registration
nipocalimab
Imaavy (nipocalimab-aahu)
Acquired (Autoimmune) Hemolytic Anemia
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 3
obecabtagene autoleucel
Aucatzyl (obecabtagene autoleucel)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
B-lymphocyte antigen CD19
$AUTLAutolus Therapeutics plc
0 catalysts
Phase 3
obexelimab
Immunoglobulin G4-Related Disease (IgG4-RD)
B-lymphocyte antigen CD19Low affinity immunoglobulin gamma Fc region receptor II-b
$ZBIOZenas BioPharma, Inc.
0 catalysts
Marketed
omalizumab
Xolair (omalizumab)
Chronic Urticaria
Genentech Inc
0 catalysts
Phase 3
onvuzosiran sodium
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
ADARx Pharmaceuticals Inc
0 catalysts
Phase 2
orismilast
orismilast [INN]
Plaque Psoriasis (Psoriasis Vulgaris)
Union Therapeutics AS
0 catalysts
Marketed
oxaprozin
Coxanto (oxaprozin)
Juvenile Rheumatoid Arthritis
Solubiomix LLC
0 catalysts
Phase 2
ozureprubart
Food Allergy
RAPT Therapeutics Inc
0 catalysts
Marketed
peanut (Arachis hypogaea) allergen
Palforzia
Peanut Allergy
Aimmune Therapeutics Inc
0 catalysts
Phase 2
pegtarazimod hydrochloride
Chronic Obstructive Pulmonary Disease (COPD)
ReAlta Life Sciences Inc
0 catalysts
Phase 3
piclidenoson
Plaque Psoriasis (Psoriasis Vulgaris)
Adenosine receptor A3
$CANFCan-Fite BioPharma Ltd.
0 catalysts
Marketed
ponesimod
Ponvory (ponesimod)
Ulcerative Colitis
Sphingosine 1-phosphate receptor 1
$VNDAVanda Pharmaceuticals Inc.
0 catalysts
Phase 3
pozelimab
Veopoz (pozelimab-bbfg)
Myasthenia Gravis
Complement C5
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Marketed
prednicarbate
Prednicarbate Oceanside (prednicarbate)
Psoriasis
Oceanside Pharmaceuticals Inc
0 catalysts
Marketed
prednisolone
Prednisolone (prednisolone [INN])
Allergic Conjunctivitis
Teva Pharmaceuticals USA Inc
0 catalysts
Marketed
prednisolone sodium phosphate
Prednisolone Sodium Phosphate (prednisolone sodium phosphate)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Mission Pharmacal Co
0 catalysts
Marketed
prednisone
Prednisone (prednisone [INN])
Aspiration Pneumonitis
Vintage Pharmaceuticals Inc (Inactive)
0 catalysts
Marketed
promethazine
Promethazine Hydrochloride (promethazine [INN])
Allergic Conjunctivitis
Nostrum Laboratories LLC
0 catalysts
Phase 1
prulacabtagene leucel
B-Cell Non-Hodgkin Lymphoma
$ACETAdicet Bio, Inc.
0 catalysts